Chicos FAS Inc (CHS) Stock Fundamental Analysis
NYSE:CHS - New York Stock Exchange, Inc. - US1686151028 - Common Stock - Currency: USD
CHS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CHS get a neutral evaluation. Nothing too spectacular is happening here. CHS has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CHS had positive earnings in the past year.
In the past year CHS had a positive cash flow from operations.
In multiple years CHS reported negative net income over the last 5 years.
CHS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.82%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
CHS has a better Return On Equity (26.40%) than 79.84% of its industry peers.
CHS's Return On Invested Capital of 12.31% is fine compared to the rest of the industry. CHS outperforms 77.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROIC | 12.31% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHS has a Profit Margin of 5.29%. This is in the better half of the industry: CHS outperforms 72.87% of its industry peers.
CHS's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 6.16%, CHS is doing good in the industry, outperforming 68.22% of the companies in the same industry.
CHS's Operating Margin has improved in the last couple of years.
The Gross Margin of CHS (38.94%) is comparable to the rest of the industry.
CHS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% |
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
CHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CHS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHS has less shares outstanding
Compared to 1 year ago, CHS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.22 indicates that CHS is not in any danger for bankruptcy at the moment.
The Altman-Z score of CHS (3.22) is better than 70.54% of its industry peers.
The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CHS (0.42) is better than 82.17% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that CHS is not too dependend on debt financing.
CHS's Debt to Equity ratio of 0.06 is fine compared to the rest of the industry. CHS outperforms 75.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.34
WACC9.19%
2.3 Liquidity
CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHS (1.20) is worse than 72.09% of its industry peers.
CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
CHS has a worse Quick ratio (0.42) than 60.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
CHS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
CHS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.10% yearly.
Looking at the last year, CHS shows a decrease in Revenue. The Revenue has decreased by -0.24% in the last year.
Measured over the past years, CHS shows a decrease in Revenue. The Revenue has been decreasing by -1.26% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
3.2 Future
CHS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.47% yearly.
Based on estimates for the next years, CHS will show a small growth in Revenue. The Revenue will grow by 0.60% on average per year.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.86, the valuation of CHS can be described as very reasonable.
Based on the Price/Earnings ratio, CHS is valued a bit cheaper than the industry average as 79.07% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CHS to the average of the S&P500 Index (27.03), we can say CHS is valued rather cheaply.
The Price/Forward Earnings ratio is 10.29, which indicates a very decent valuation of CHS.
Based on the Price/Forward Earnings ratio, CHS is valued a bit cheaper than 74.42% of the companies in the same industry.
CHS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHS is valued cheaper than 85.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHS is valued a bit cheaper than the industry average as 67.44% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.37 | ||
| EV/EBITDA | 4.72 |
4.3 Compensation for Growth
The decent profitability rating of CHS may justify a higher PE ratio.
CHS's earnings are expected to decrease with -8.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.59
-0.01 (-0.13%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 | ||
| P/S | 0.44 | ||
| P/FCF | 16.37 | ||
| P/OCF | 8.25 | ||
| P/B | 2.22 | ||
| P/tB | 2.34 | ||
| EV/EBITDA | 4.72 |
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROCE | 15.79% | ||
| ROIC | 12.31% | ||
| ROICexc | 14.55% | ||
| ROICexgc | 15.01% | ||
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% | ||
| FCFM | 2.71% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Debt/EBITDA | 0.14 | ||
| Cap/Depr | 134.65% | ||
| Cap/Sales | 2.67% | ||
| Interest Coverage | 35.98 | ||
| Cash Conversion | 66.14% | ||
| Profit Quality | 51.32% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 3.22 |
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%